Workhorse Shareholders Approve Merger with Motiv Electric Trucks
Globenewswire· 2025-11-25 21:05
CINCINNATI, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Workhorse Group, Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today announced that at the 2025 Annual Meeting of Shareholders (the “Annual Meeting”) held earlier today, Workhorse shareholders voted to approve the merger with Motiv Electric Trucks (“Motiv”). “We appreciate the support of our shareholders as we reach this important milestone in our pend ...
Ambarella, Inc. Announces Third Quarter Fiscal Year 2026 Financial Results
Globenewswire· 2025-11-25 21:05
SANTA CLARA, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced financial results for its third quarter of fiscal year 2026 ended October 31, 2025. Revenue for the third quarter of fiscal 2026 was $108.5 million, up 31.2% from $82.7 million in the same period in fiscal 2025. For the nine months ended October 31, 2025, revenue was $289.8 million, up 44.3% from $200.9 million for the nine months ended October 31, 2024.Gross margin under ...
Critical Metals Corp Provides an Update on the Wolfsberg Lithium Project
Globenewswire· 2025-11-25 21:05
NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, today announced that ECM Lithium AT GmbH has received the decision of the Federal Administrative Court in the appeal proceedings concerning the requirement for an environmental impact assessment (EIA) for its "Koralpe Lithium Mining" project. The Federal Administrative Court overturned the decision of the Carinthian state government, which ha ...
O-I Glass to Present at Citi's 2025 Basic Materials Conference
Globenewswire· 2025-11-25 21:05
PERRYSBURG, Ohio, Nov. 25, 2025 (GLOBE NEWSWIRE) -- O-I Glass, Inc. (“O-I Glass” or “O-I”) today announced the Company will participate in Citi’s 2025 Basic Materials Conference on Wednesday, December 3, 2025. O-I Glass Chief Executive Officer Gordon Hardie and Chief Financial Officer John Haudrich will present at 11:30 a.m. ET. A live webcast of the presentation will be available at https://kvgo.com/2025-basic-materials-conference/o-i-glass-inc-december or can be accessed on the Company’s Investor Relation ...
Aardvark Therapeutics to Present at Upcoming Investor Conferences in December
Globenewswire· 2025-11-25 21:05
SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, announced that it will present at the following conferences during December: Piper Sandler 37th Annual Healthcare Conference in New YorkPresentation: Wednesday, December 3 at 8:00 a.m. ETEvercore ISI 8th Annual Healthcare Conferenc ...
Allegro MicroSystems to Present at the 53rd Annual Nasdaq Investor Conference held in Association with Morgan Stanley Wednesday, December 10, 2025
Globenewswire· 2025-11-25 21:05
MANCHESTER, N.H., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced that the company will present at the 53rd Annual Nasdaq Investor Conference held in Association with Morgan Stanley on Wednesday, December 10, 2025 at The May Fair Hotel in London, United Kingdom. Derek D’Antilio, EVP and Chief Financial Officer, and Mark Gill, VP Corporate Stra ...
Abacus Global Management Announces Timing of Inaugural Dividend Distribution
Globenewswire· 2025-11-25 21:05
~ Dividend Distribution Advances Shareholder-Focused Capital Program ~ ORLANDO, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (Nasdaq: ABL), a leader in the alternative asset management industry, today announced the timing of its previously announced inaugural annual cash dividend to shareholders, as approved by its Board of Directors. The Company’s Board of Directors has declared an annual cash dividend of $0.20 per share, payable on December 17, 2025, t ...
CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting
Globenewswire· 2025-11-25 21:05
Two late-breaking podium presentations and three posters continue to demonstrate cretostimogene as a potential backbone therapy for a broad range of NMIBC patientsIRVINE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced two late breaking podium presentations on the topline results from BOND-003 ...
Star Equity Holdings to Present at the Noble Capital Markets Emerging Growth Conference on December 3, 2025
Globenewswire· 2025-11-25 21:05
OLD GREENWICH, Conn., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR and STRRP) formerly, Hudson Global, Inc. (Nasdaq: HSON and HSONP) (“Star” or the “Company”), a diversified holding company, announced today that its management team will be presenting at the Noble Capital Markets Emerging Growth Conference, scheduled to be held on December 3, 2025, at Florida Atlantic University in Boca Raton, Florida. Star’s main presentation is scheduled for 1:30 pm ET. A webcast of the presen ...
FibroBiologics Announces Closing of $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Globenewswire· 2025-11-25 21:05
HOUSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of an aggregate of 4,477,614 shares of its common stock ...